Therapeutic use of granulocyte-colony stimulating factor could conceal residual malignant cells in patients with AML1/ETO⁺ acute myelogenous leukemia

H. W. Moon, S. Shin, H. Y. Kim, Y. R. Kim, H. I. Cho, S. S. Yoon, S. Park, B. K. Kim, H. Chun, H. C. Kim, C. J. Park, Y. H. Min, D. Soon Lee^*

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review